Author

R. Palankar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

A. Greinacher· 3 shared J. Wesche· 2 shared L. Sachs· 2 shared M. Bender· 2 shared O. Otto· 2 shared C. Wolz· 1 shared C. Zaninetti· 1 shared H. von Eysmondt· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

A. Greinacher

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Ex vivo anticoagulants affect human blood platelet biomechanics with implications for high-throughput functional mechanophenotyping.

L. Sachs, J. Wesche, L. Lenkeit, A. Greinacher, M. Bender, O. Otto, R. Palankar

This study shows ex vivo anticoagulants affect platelet biomechanics and demonstrates their impact on mechanophenotyping in a MYH9-related disorder.

Communications Biology · Jan 21, 2022Peer-reviewedCell Biology

Alpha-hemolysin of Staphylococcus aureus impairs thrombus formation

K. Jahn, S. Handtke, R. Palankar, T. P. Kohler, J. Wesche, M. Wolff, J. Bayer, C. Wolz, A. Greinacher, S. Hammerschmidt

This study shows that Staphylococcus aureus alpha-hemolysin activates and then damages platelets, impairing thrombus formation and stability, and is not neutralized by polyvalent immunoglobulins.

bioRxiv · Nov 11, 2021Microbiology

Reduced platelet forces underlie impaired hemostasis in mouse models of MYH9-related disease

J. Baumann, L. Sachs, O. Otto, I. Schoen, P. Nestler, C. Zaninetti, M. Kenny, R. Kranz, H. von Eysmondt, J. Rodriguez, T. Schaeffer, Z. Nagy, A. Greinacher, R. Palankar, M. Bender

This study shows that reduced platelet forces in Myh9 mutant mice cause impaired hemostasis, which can be improved by tranexamic acid.

bioRxiv · Nov 10, 2021Cell Biology